Clinical Research Directory

Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis

Sponsor: Oslo University Hospital

Summary

The aim of the present study is to investigate the effect of probiotic supplementation on GI related quality of life, through a randomised placebo-controlled clinical trial. Moreover, the invetigators wish to study CF microbiota and intestinal inflammation in the setting of probiotic supplementation and newly started treatment with a highly effective CF-specific treatment, elexacaftor-tezacaftor-ivacaftor (ETI). The proposed project has the potential to increase QoL and decrease GI morbidity in children with CF. If successful, the results of this study can contribute to alter the care of CF patients by including supplementation of probiotics in routine CF care. Morever, the study can provide much needed insights to GI microbiota and inflammation in pediatric CF patients.

Official title: Probiotic Supplementation, Quality of Life and Gut Health in Pediatric Patients With Cystic Fibrosis

Key Details

Conditions

Interventions

Locations (1)